Shi Fu-Dong

Fu-Dong Shi is a Professor and Chair of the Division of Neuroimmunology at Beijing Tiantan Hospital, affiliated with Capital Medical University, China. He concurrently serves as Visiting Professor at Charité – Universitätsmedizin Berlin (Germany), Chief Neurologist at BTCN (Beijing-Tianjin Center for Neuroinflammation), and Board Member of the European Charcot Foundation. His career spans roles as Vice President/Chairman of Neurology departments at Tianjin Medical University General Hospital and Director of BTCN under China’s National Clinical Research Center for Neurological Diseases.

• Education: PhD from Karolinska Institute (Sweden), Postdoctoral training at Scripps Research Institute (USA), Clinical training at Harbin Medical University and Peking Union Hospital (China).

Research focuses on neuro-immune interactions, stroke immunology, and neuroinflammatory disorders. He pioneered therapies targeting brain inflammation in stroke and developed diagnostic platforms for neurological diseases. His work includes 258 publications and 28 patents.

Awards highlight his contributions to neurology and stroke research, including national excellence awards in China and international recognition. He leads multi-center clinical trials and fosters Sino-European collaborations through editorial roles at Science Translational Medicine and Cell Death & Differentiation.

Notable initiatives include BTCN’s global patient care and drug development pipelines. His leadership bridges Chinese and European neurology communities through education and research partnerships.